BMS-903452

CAS No. 1339944-47-6

BMS-903452( —— )

Catalog No. M35988 CAS No. 1339944-47-6

BMS-903452 is a potent and selective GPR119 agonist with an EC50 of 14 nM, indicated for the treatment of acute and chronic rodent diabetes.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 234 Get Quote
5MG 366 Get Quote
10MG 520 Get Quote
25MG 756 Get Quote
50MG 1021 Get Quote
100MG 1350 Get Quote
500MG 2646 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    BMS-903452
  • Note
    Research use only, not for human use.
  • Brief Description
    BMS-903452 is a potent and selective GPR119 agonist with an EC50 of 14 nM, indicated for the treatment of acute and chronic rodent diabetes.
  • Description
    BMS-903452 is a potent and selective GPR119 agonist for diabetes research.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    GPR
  • Recptor
    GPR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1339944-47-6
  • Formula Weight
    513.37
  • Molecular Formula
    C21H19Cl2FN4O4S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C1N(C=C(Cl)C(OC2CCN(CC2)C=3N=CC(Cl)=CN3)=C1)C4=C(F)C=C(S(C)(=O)=O)C=C4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Wacker DA, et al. Discovery of 5-chloro-4-((1-(5-chloropyrimidin-2-yl)piperidin-4-yl)oxy)-1-(2-fluoro-4-(methylsulfonyl)phenyl)pyridin-2(1H)-one (BMS-903452), an antidiabetic clinical candidate targeting GPR119. J Med Chem. 2014 Sep 25;57(18):7499-508.?
molnova catalog
related products
  • MK-6892

    MK-6892 is a selective and full agonist for the high-affinity nicotinic acid receptor GPR109A (Ki: 4 nM; GTPγS EC50: 16 nM).MK-6892 evokes a potent internalization of GPR109A in U2OS β-arrestin2-RrGFP cells.MK-6892 shows an EC50 value of 74 nM on calcium mobilization assay.

  • SB271046

    SB271046 is a potent, selective and orally active 5-HT6 receptor antagonist with pKi of 8.9, exhibits 200-fold greater selectivity over other 5-HT receptor subtypes.

  • Gly-Leu

    Gly-Leu is a substrate for the assay of glycyl-L-leucine dipeptidase.